Report - 3rd Listen and Learn Focus Group (LLFG) meeting of the Quality Innovation Group (QIG)
Human medicines European public assessment report (EPAR): Buccolam, midazolam, Date of authorisation: 04/09/2011, Revision: 21, Status: Authorised
ETF statement on the use of Imvanex for the prevention of mpox in children below 12 years of age
Human medicines European public assessment report (EPAR): Alecensa, alectinib, Date of authorisation: 16/02/2017, Revision: 16, Status: Authorised
PSUSA/00001890/202401
Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - February, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 February 2025 to 20 February 2025
Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - May, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 May 2025 to 7 May 2025
Agenda - Second European Medicines Agency (EMA) and IPFA - PPTA global bilateral meeting
Medicinal products for human use: monthly figures - October 2024
New fee regulation: webinar for industry stakeholders (human), Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 October 2024, 10:30 (CEST) to 24 October 2024, 11:30 (CEST)